F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Nonalcoholic fatty liver disease

Page 1 of 5 ( 233 items )
<<
1
2
3
4
5
>>

1	Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard 5/26/2025 7:26:12 AM \| Browse: 45 \| Download: 386
2	Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations 3/26/2025 4:06:58 AM \| Browse: 65 \| Download: 211
3	Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen 3/26/2025 4:06:56 AM \| Browse: 62 \| Download: 258
4	What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? 12/30/2024 9:49:59 AM \| Browse: 94 \| Download: 375
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 101 \| Download: 461
6	Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology 11/29/2024 2:50:19 PM \| Browse: 118 \| Download: 635
7	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 111 \| Download: 611
8	Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future 10/31/2024 10:42:49 AM \| Browse: 123 \| Download: 429
9	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 107 \| Download: 423
10	Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis 7/17/2024 5:55:51 AM \| Browse: 125 \| Download: 607
11	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 150 \| Download: 626
12	Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 137 \| Download: 500
13	Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study 6/20/2024 3:42:22 AM \| Browse: 186 \| Download: 696
14	Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 190 \| Download: 512
15	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 172 \| Download: 478
16	Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions 4/12/2024 4:45:44 PM \| Browse: 186 \| Download: 534
17	Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis 3/27/2024 1:28:19 PM \| Browse: 192 \| Download: 739
18	Metabolic disease and the liver: A review 1/23/2024 9:31:45 AM \| Browse: 299 \| Download: 813
19	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 243 \| Download: 863
20	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 295 \| Download: 1121
21	Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway 8/18/2023 10:08:22 AM \| Browse: 319 \| Download: 1339
22	Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value 6/25/2023 2:17:08 PM \| Browse: 297 \| Download: 938
23	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 317 \| Download: 974
24	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 335 \| Download: 1116
25	Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease 2/24/2023 1:35:50 PM \| Browse: 370 \| Download: 1199
26	Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status 2/24/2023 1:35:50 PM \| Browse: 371 \| Download: 1062
27	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 376 \| Download: 968
28	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 364 \| Download: 1139
29	Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome 11/16/2022 11:26:06 AM \| Browse: 497 \| Download: 1218
30	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 505 \| Download: 1544
31	Rare leptin in non-alcoholic fatty liver cirrhosis: A case report 9/27/2022 1:00:18 PM \| Browse: 406 \| Download: 1354
32	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 510 \| Download: 1640
33	Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease 9/15/2022 1:37:25 PM \| Browse: 513 \| Download: 1343
34	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 575 \| Download: 1424
35	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 485 \| Download: 1202
36	Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 523 \| Download: 1086
37	Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 510 \| Download: 1518
38	Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives 7/18/2022 9:47:46 AM \| Browse: 591 \| Download: 1371
39	Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease 7/18/2022 9:47:46 AM \| Browse: 687 \| Download: 1746
40	Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases 7/13/2022 7:31:00 AM \| Browse: 438 \| Download: 1309
41	Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments 7/4/2022 12:30:52 PM \| Browse: 582 \| Download: 2099
42	Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus 6/23/2022 2:39:01 PM \| Browse: 511 \| Download: 1507
43	Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in children: A case report 6/17/2022 3:19:27 AM \| Browse: 504 \| Download: 1446
44	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 582 \| Download: 1418
45	Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities 5/18/2022 11:24:37 AM \| Browse: 531 \| Download: 1482
46	Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics 5/10/2022 9:43:36 AM \| Browse: 572 \| Download: 1358
47	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 540 \| Download: 1630
48	Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice 4/29/2022 6:42:52 AM \| Browse: 642 \| Download: 2250
49	Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B 4/22/2022 10:52:23 AM \| Browse: 534 \| Download: 1412
50	Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease 4/15/2022 8:25:28 AM \| Browse: 587 \| Download: 2140

Page 1 of 5 ( 233 items )
<<
1
2
3
4
5
>>

1	Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard 5/26/2025 7:26:12 AM \| Browse: 45 \| Download: 386
2	Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations 3/26/2025 4:06:58 AM \| Browse: 65 \| Download: 211
3	Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen 3/26/2025 4:06:56 AM \| Browse: 62 \| Download: 258
4	What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development? 12/30/2024 9:49:59 AM \| Browse: 94 \| Download: 375
5	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 101 \| Download: 461
6	Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology 11/29/2024 2:50:19 PM \| Browse: 118 \| Download: 635
7	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 111 \| Download: 611
8	Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future 10/31/2024 10:42:49 AM \| Browse: 123 \| Download: 429
9	Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis 10/25/2024 3:02:15 AM \| Browse: 107 \| Download: 423
10	Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis 7/17/2024 5:55:51 AM \| Browse: 125 \| Download: 607
11	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 150 \| Download: 626
12	Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 137 \| Download: 500
13	Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study 6/20/2024 3:42:22 AM \| Browse: 186 \| Download: 696
14	Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 190 \| Download: 512
15	Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease 5/27/2024 9:35:51 AM \| Browse: 172 \| Download: 478
16	Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions 4/12/2024 4:45:44 PM \| Browse: 186 \| Download: 534
17	Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis 3/27/2024 1:28:19 PM \| Browse: 192 \| Download: 739
18	Metabolic disease and the liver: A review 1/23/2024 9:31:45 AM \| Browse: 299 \| Download: 813
19	Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1 12/27/2023 5:42:53 AM \| Browse: 243 \| Download: 863
20	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 295 \| Download: 1121
21	Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway 8/18/2023 10:08:22 AM \| Browse: 319 \| Download: 1339
22	Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value 6/25/2023 2:17:08 PM \| Browse: 297 \| Download: 938
23	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 317 \| Download: 974
24	Emerging role of engineered exosomes in nonalcoholic fatty liver disease 3/22/2023 11:20:34 AM \| Browse: 335 \| Download: 1116
25	Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease 2/24/2023 1:35:50 PM \| Browse: 370 \| Download: 1199
26	Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status 2/24/2023 1:35:50 PM \| Browse: 371 \| Download: 1062
27	Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma 1/6/2023 2:52:58 AM \| Browse: 376 \| Download: 968
28	Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies 1/4/2023 5:53:01 AM \| Browse: 364 \| Download: 1139
29	Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome 11/16/2022 11:26:06 AM \| Browse: 497 \| Download: 1218
30	Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease 10/28/2022 7:46:25 AM \| Browse: 505 \| Download: 1544
31	Rare leptin in non-alcoholic fatty liver cirrhosis: A case report 9/27/2022 1:00:18 PM \| Browse: 406 \| Download: 1354
32	Heredity hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study 9/23/2022 12:48:56 AM \| Browse: 510 \| Download: 1640
33	Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease 9/15/2022 1:37:25 PM \| Browse: 513 \| Download: 1343
34	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 575 \| Download: 1424
35	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 485 \| Download: 1202
36	Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 523 \| Download: 1086
37	Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 510 \| Download: 1518
38	Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives 7/18/2022 9:47:46 AM \| Browse: 591 \| Download: 1371
39	Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease 7/18/2022 9:47:46 AM \| Browse: 687 \| Download: 1746
40	Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases 7/13/2022 7:31:00 AM \| Browse: 438 \| Download: 1309
41	Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments 7/4/2022 12:30:52 PM \| Browse: 582 \| Download: 2099
42	Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus 6/23/2022 2:39:01 PM \| Browse: 511 \| Download: 1507
43	Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in children: A case report 6/17/2022 3:19:27 AM \| Browse: 504 \| Download: 1446
44	Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis 5/24/2022 10:35:19 AM \| Browse: 582 \| Download: 1418
45	Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities 5/18/2022 11:24:37 AM \| Browse: 531 \| Download: 1482
46	Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics 5/10/2022 9:43:36 AM \| Browse: 572 \| Download: 1358
47	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 540 \| Download: 1630
48	Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice 4/29/2022 6:42:52 AM \| Browse: 642 \| Download: 2250
49	Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B 4/22/2022 10:52:23 AM \| Browse: 534 \| Download: 1412
50	Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease 4/15/2022 8:25:28 AM \| Browse: 587 \| Download: 2140